Egl nine homolog 1; hypoxia-inducible factor prolyl hydroxylase 2; HIF-PH2; HIF-prolyl hydroxylase 2; HPH-2; prolyl hydroxylase domain-containing protein 2; PHD2; SM-20 (EGLN1, C1orf12, PNAS-118, PNAS-137)
Jump to navigation
Jump to search
Function
- catalyzes post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins
- hydroxylates HIF-1 alpha at Pro-402 & Pro-564, & HIF-2 alpha
- functions as a cellular oxygen sensor &, under normoxic conditions, targets HIF through the hydroxylation for proteasomal degradation via the VCB complex (von Hippel-Lindau ubiquitination complex)
- following exposure to hypoxia
- activated in HeLa cells
- not activated in cardiovascular cells
- seems to be inhibited by ING4
HIF alpha chain L-proline + 2-oxoglutarate + O2 = HIF alpha chain trans-4-hydroxy-L-proline + succinate + CO2
Structure
- monomer
- contains 1 Fe2OG dioxygenase domain
- contains 1 MYND-type Zn+2 finger
Alternative splicing
named isoforms=2
Expression
- widely expressed
- expressed in brain, skeletal muscle & heart, pancreas, kidney, adrenal, lung & liver
- in brain expressed in dopaminergic neurons of adult & fetal substantia nigra
- expressed in cardiac myocytes, aortic endothelial cells & coronary artery smooth muscle
Pathology
- defects in EGLN1 are the cause of erythrocytosis familial type 3
More general terms
Additional terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/Q9GZT9.html
- ↑ Atlas of Genetics & Cytogenetics in Oncology & Haematology http://atlasgeneticsoncology.org/genes/EGLN1ID44140ch1q42.html